|
|
National Center for Chronic Disease Prevention and Health Promotion
Division of Adult and Community Health
Health Care and Aging Studies Branch
Arthritis Program
Mailstop K-51
4770 Buford Highway NE
Atlanta, GA 30341-3724
Phone: 770.488.5464
Fax: 770.488.5964
Email Us |
|
|
|
|
Arthritis Types — Overview
Arthritis—General
I. Background
- Arthritis can be defined clinically, epidemiologically, or in
other ways depending on the analyst's perspective. Here we use
two standard approaches for defining arthritis:
- For estimating population prevalence using self-report surveys,
we use the case definition of “doctor-diagnosed
arthritis”—defined by answering ‘yes’ to the question “Have you
EVER been told by a doctor or other health professional that you
have some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?”
This question is used by the Behavior Risk Factor Surveillance
System (2002 and later) and the National Health Interview Survey
(2002 and later). Because respondents are frequently not familiar
with their specific types of arthritis, such self-report data are
used only for the most generic definition of arthritis, where any
misclassification is likely to occur between arthritis categories
already included in the case definition.
- For estimates from health care system or other data using
ICD-9-CM codes, we use a standard
set of ICD-9-CM codes
(PDF-26K) for
“arthritis and other rheumatic conditions” (AORC) developed
by the National Arthritis Data Workgroup in 1994.
- Diagnosis. Most of these diseases are clinically diagnosed using
the patient’s history, physical examination, and selected, supportive
radiographic and laboratory studies. Only a few of these diseases
(e.g., gout) have a definitive diagnosis.
- Treatments. Non-inflammatory types are usually treated with pain
medications, physical activity, weight loss (if overweight), and
self-management education. Inflammatory types are treated with these
modalities as well as anti-inflammatory medications (corticosteroids
and nonsteroidal anti-inflammatory drugs (NSAIDs)), disease-modifying
anti-rheumatic drugs (DMARDs), and a relatively new class of drugs
known as biologic agents.
Back to top
Back to Overview
II. Prevalence
- About 21% of U.S. adults, or 46.4 million people aged 18 years
or older, have self-reported doctor-diagnosed arthritis among the
civilian, non-institutionalized population. 1
- Prevalence proportions for adults were higher among:
- Older adults (50% for persons aged >65 years, 29.3% for
persons age 45–64 years, and 7.9% for persons aged 18–44 years).1
- Females (age-adjusted: 24.4% among women versus 18.1% among
men).1
- Non-Hispanic whites and blacks (age-adjusted: 22.6% and
21.4%) versus Hispanics (16.5%) and other non-Hispanics (17.3%).1
- Obese and overweight people. Obese (age-adjusted: 29.3%)
versus overweight (20.5%) or underweight/normal weight (17.4%).1
- Physically inactive people (age-adjusted: 22.3% for
physically inactive versus 20.8% among physical active).1
- About 8% of U.S. adults, or 18.9 million people aged 18 years or
older, have arthritis attributable activity limitations,1
defined as a "yes" answer to "Are you now limited in any way in any
of your usual activities because of arthritis or joint symptoms?"
Back to top
Back to Overview
III. Incidence
- Incidence data are not available.
Back to top
Back to Overview
IV. Mortality
- Mortalitiy data for 20-year period 1979-1998 estimated 146,377
deaths with an underlying cause of arthritis and other rheumatic
conditions (AORC). Deaths rose from 5537/year to 9367/year during
that period,
corresponding to an age-standardized annual rate of ~3/100,000.2
- Deaths occurred among all age groups, including children; 12.1%
occurred among persons aged 15–44.2
- Age-standardized death rates were higher for women and blacks.2
- Using 10 categories of AORC, three accounted for almost 80% of deaths:
diffuse connective tissues diseases (34%; mostly systemic lupus erythematosus and systemic sclerosis), other specified rheumatic
conditions (23%, mostly vasculitis), and rheumatoid arthritis (22%).2
- During the 20-year period an additional 585,446 persons had AORC
listed as an associated cause of death.2
Back to top
Back to Overview
V. Hospitalizations
- 1997 data from the National Hospital Discharge Survey estimated 744,000
hospitalizations with a principal diagnosis of AORC.3
These people were older, had fewer comorbidities, had shorter stays,
were more like to undergo a procedure, and were more likely to be
discharged to short- and long-term care facilities than people with nonarthritis hospitalizations. The most common diagnoses and
procedures related to osteoarthritis. This profile is consistent
with a healthier-than-average hospital population electively
admitted for specific procedures and subsequent rehabilitation.3
- In 1997 there were an additional 1.76 million hospitalizations
with AORC as a secondary diagnosis.
These people were older, had more comorbidities, and a longer
hospital stay than those with nonarthritis hospitalizations. This
profile consistent with a sicker-than-average hospital population
non-electively admitted for reasons other than their AORC,
especially cardiovascular disease, with AORC complicating their
hospitalization.3
- More than 9% of all disease-related hospitalizations involved AORC.3
Back to top
Back to Overview
VI. Ambulatory Care
- Using 1997 data from the National Ambulatory medical Care Survey (NAMCS)
and the National Hospital Ambulatory medical Care Survey (NHAMCS),
there were an estimated 36.5 million visits for a primary diagnosis of AORC to
physician offices (89%), and acute care hospital outpatient (7%) and
emergency departments (4%).4
This number exceeded that for other common chronic conditions, such
as cardiovascular
disease and other circulatory diseases, essential hypertension,
asthma/COPD/chronic bronchitis, cancer, and diabetes mellitus.4
- Persons of all ages made these visits, although the proportions were
greatest among older ages; women had almost twice as many visits as
men.4
- For office visits the most frequent specialties involved were primary care
physicians (52.9%), orthopedic surgeons (19.6%), and rheumatologists
(16.5%). Other office staff involved in care included nursing staff
(50.6%, or over 16.4 million visits) and mid-level practitioners (2.5%,
or over 800,000 visits).4
- Four of 10 AORC categories accounted for almost 75%
of visits: soft tissue disorders excluding back (25.5%),
osteoarthritis and allied disorders (19.5%), joint pain/effusion/
other unspecified joint disorders (19.2%), and rheumatoid arthritis
(10.9%).4
Back to top
Back to Overview
VII. Cost
- Conservative analyses based on the 2003 Medical Expenditures
Panel Survey (MEPS) estimated costs due to arthritis of $128
billion, up 48% from $86.2 billion in 1997 (or up 24% in constant 2003 dollars).
The direct cost (medical expenditures) attributable to AORC were
$80.8 billion and the indirect cost (earnings losses) were $47.0
billion. [These analyses adjusted for six demographic characteristics,
nine expensive comorbidities, and health insurance status.]5
- The largest components of direct costs were for ambulatory care
(52.1%), inpatient care (20.0%), and prescription drugs (19.3%).5
Back to top
Back to Overview
VIII. Impact on health-related quality of life (HRQOL)
- No HRQOL measures exist that use either of the current arthritis case definitions
listed above.
- Analyses using a case definition roughly equivalent to
“doctor-diagnosed arthritis OR possible arthritis”, although with
slightly different questions, showed that adults with arthritis had
significantly worse HRQOL than those without arthritis. This was
true for self-reported fair/poor health (23.8 vs. 7.3%) and, in the
past month, the number of physically unhealthy days (~5.0 vs. 1.0),
mentally unhealthy days (~3.5 vs. 1.7), (physical or mental unhealthy days (~7.6 vs. 2.5), and activity limitation days
(~3.0 vs. 0.7).6
Those especially affected were people in these categories: aged 45–64 years, blacks, Hispanics,
separated marital status, less than a high school education, unemployed for more
than one year, homemakers, those unable to work, the physically
inactive, those who were underweight, those who lacked health care
coverage or insurance, those who currently smoke, and those who did
not drink alcohol.6
Back to top
Back to Overview
IX. Unique characteristics
- State specific prevalence
estimates for 2007 and projections to 20307 for doctor-diagnosed
arthritis and arthritis-attributable activities limitations are
available.
- These generic arthritis estimates are driven primarily by the most common type of
arthritis—osteoarthritis.
Back to top
Back to Overview
X. References
- Hootman J, Bolen J, Helmick C, Langmaid G. Prevalence of
Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity
Limitation—United States, 2003-2005. MMWR [View the errata for this article
here
and here.] 2006;55(40):1089–1092.
- Sacks JJ, Helmick CG, Langmaid G. Deaths from arthritis and
other rheumatic conditions, United States, 1979–1998. J Rheumatol
2004;31:1823–1828.
- Lethbridge-Cejku M, Helmick CG, Popovic JR. Hospitalizations
for arthritis and other rheumatic conditions: Data from the 1997
National Hospital Discharge Survey. Medical Care
2003;41(12):1367–1373.
- Hootman JM, Helmick CG, Schappert SM. Magnitude and
characteristics of arthritis and other rheumatic conditions on
ambulatory medical care visits, United States, 1997. Arthritis Rheum (Arthritis Care & Research) 2002;46(6):571–581.
- Yelin E, Murphy L, Cisternas MG, Foreman AJ, Pasta DJ, Helmick
CG. Medical care expenditures and earnings losses among persons with
arthritis and other rheumatic conditions in 2003, and comparisons
with
1997. Arthritis Rheum 2007;56(5):1397–1407.
- Mili F, Helmick CG, Zack MM, Moriarty DG. Health related
quality of life among adults reporting arthritis: Analysis of data
from the Behavioral Risk Factor Surveillance System, US, 1996–1999.
J Rheumatol 2003;30(1):160–166.
- Freedman M, Hootman JM, Helmick CG. Projected State-Specific
Increases in Self-Reported Doctor-Diagnosed Arthritis and
Arthritis-Attributable Activity Limitations—United States, 2005–2030.
MMWR [View the errata for this article
here] 2007;56(17):423-425.
Back to top
Back to Overview
Some documents on this page are available in Portable Document Format (PDF). Learn more
about viewing and printing PDF documents with
Acrobat Reader.
Page last reviewed: June 8, 2008
Page last modified: January 11, 2008 Content Source:
Division of
Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion
|
|